4 not yet recruiting, 1 completed, 1 recruiting. 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Not yet recruiting 4, Completed 1, Recruiting 1 |
Follow Acute Myocardial Infarction (AMI): new trials by email Literature Review of Acute Myocardial Infarction (AMI) trials Research Report on Acute Myocardial Infarction (AMI)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Timing of Empagliflozin in Primary PCI: Pre-Reperfusion Versus Post-Reperfusion Versus Placebo in South Asian STEMI Patients empagliflozin, Placebo - ST-elevation Myocardial Infarction (STEMI), Acute Myocardial Infarction (AMI) | Phase 2 | Not yet recruiting | Rehman Medical Institute - RMI | 480 | 2026-09-01 | 2026-08-06 |
| Combined Antioxidant Therapy for Acute Myocardial Infarction Combined antioxidant therapy, Placebo - Acute Myocardial Infarction (AMI), ST Elevation (STEMI) Myocardial Infarction | Phase 2 | Not yet recruiting | University of Chile | 46 | 2026-09-01 | 2026-08-20 |
| Recombinant Human Thymosin Beta 4 for Injection(NL005) for Acute Myocardial Infarction Recombinant Human Thymosin Beta 4 Injection (NL005), Placebo - Acute Myocardial Infarction (AMI), Acute Myocardial Infarction of Anterior Wall | Phase 2 | Not yet recruiting | Beijing Northland Biotech. Co., Ltd. | 189 | 2026-05-18 | 2026-05-14 |
| Effect of Montelukast on Inflammatory Markers and Cardiac Injury in Patients With Acute Myocardial Infarction Montelukast 10 Mg Oral Tablet, placebo - Acute Myocardial Infarction (AMI) | Phase 2 | Recruiting | October 6 University | 80 | 2026-04-20 | 2026-05-08 |
| Safety and Efficacy of MiSaver (CB Cells) for Acute Myocardial Infarction, Phase II Cord Blood Nucleated cells - Acute Myocardial Infarction (AMI) | Phase 2 | Not yet recruiting | HONYA Medical Co Ltd | 102 | 2026-03-30 | 2026-03-11 |
| Dexrazoxane to Protect Against Hemorrhagic STEMI Dexrazoxane, Normal Saline - Acute Myocardial Infarction (AMI) | Phase 2 | Completed | Rohan Dharmakumar | 50 | 2025-08-30 | 2026-05-26 |
ST Elevation Myocardial Infarction (4) · Myocardial Infarction (3) · Anterior Wall Myocardial Infarction (1) · Cardiovascular Diseases (1) · Coronary Artery Disease (1) · Myocardial Reperfusion Injury (1) · Reperfusion Injury (1)
Heart Diseases (5) · Infarction (5) · Ischemia (5) · Myocardial Ischemia (5) · Necrosis (5) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Vascular Diseases (5) · Cardiovascular Diseases (4) · Myocardial Infarction (2) · Postoperative Complications (2) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Cardiomyopathies (1) · Coronary Disease (1)
Dexrazoxane (1) · Saline Solution (1) · Tablets (1) · empagliflozin (1) · montelukast (1)
Beijing Northland Biotech. Co., Ltd. (1) · HONYA Medical Co Ltd (1) · October 6 University (1) · Rehman Medical Institute - RMI (1) · Rohan Dharmakumar (1) · University of Chile (1)
Australia (1) · Chile (1) · China (1) · Egypt (1) · India (1) · Pakistan (1) · Taiwan (1)
Ashraf S Niazi, MBBS, FRCP (1) · Herbert D Aronow, MD, MPH, MSCAI, FACC, MSVM (1) · Kefei Dou (1) · Keyur P Vora, MD MS FACC (1) · Kwo-Chang Ueng, PhD (1) · Miqdad A Khan, MD, FACC, FISCI, FSCAI, FACP (1) · Rohan Dharmakumar, PhD (1)